Is there any role for neoadjuvant therapy in urothelial Tis refractory to BCG therapy?  

No clear role of systemic chemotherapy prior to radical cystectomy. The latter alone is the SOC in this setting; clinical trials should be certainly considered especially in patients who either refuse or can’t tolerate radical cystectomy for BCG unresponsive high risk NMIBC.